NX-13
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NX-13, covering 2025-07-01 to 2026-06-15. Get the full timeline:
Most recent: Clinical Trial Results: Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis [Phase 2]